Table 2 Comparison of clinical indicators and HPV subtypes between SCC and AC

Age

50(43,56)

47(43,56)

0.509

Gravidity

3(2,4)

3(2,4)

0.813

Parity

1(1,2)

2(1,2)

0.092

BMI

22.89(21.08,24.93)

23.01(21.00,24.37)

0.456

RBC

4.08(3.88,4.38)

4.01(3.79,4.34)

0.205

WBC

5.47(4.56,6.58)

5.43(4.63,6.71)

0.706

PLT

209(173.00,241.57)

208(179.16,242.50)

0.959

SCCAg

1.5(0.9,2.9)

1(0.7,1.6)

 < 0.001^*

CA125

13.75(10.80,21.33)

17.50(11.55,24.85)

0.031^*

CA19-9

10.8(7.08,16.80)

12.3(8.30,21.50)

0.030^*

Neutrophil Percentage

58.1(53.00,63.50)

57.8(51.85,64.35)

0.913

Lymphocyte Percentage

31.45(27.10,36.43)

31(25.20,35.70)

0.349

CYFRA 21–1

2.4(1.78,3.40)

2.2(1.60,2.95)

0.023^*

CEA

1.8(1.10,2.80)

1.9(1.30,3.85)

0.084

Menopausal Status

0.077

 No

114(47.9%)

48(59.3%)

 Yes

124(52.1%)

33(40.7%)

Smoking History

0.479

 No

228(95.8%)

79(97.5%)

 Yes

10(4.2%)

2(2.5%)

Clinical Symptoms

0.030^*

 Asymptomatic or Other

43(18.1%)

26(32.1%)

 Contact Bleeding

129(54.2%)

37(45.7%)

 Irregular Vaginal Bleeding

66(27.7%)

18(22.2%)

HPV Subtypes

 < 0.001^*

 Low Risk

205(86.1%)

28(34.6%)

 Medium Risk

13(5.5%)

3(3.7%)

 High Risk

20(8.4%)

50(61.7%)